Skip to main content

Animations

MJFF Publications

2981 - 2990 of 8587 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non‐Hispanic Whites: The HABLE study
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/dad2.12263
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12684
    Citation Count: 8
  • Summary Details
    OPEN
    Title: The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12514
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12243
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseases
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/alz.12880
    Citation Count: 15
  • Summary Details
    OPEN
    Title: A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/trc2.12274
    Citation Count: 25
  • Summary Details
    OPEN
    Title: A Collaboration for Guiding the Rational Design of Multielement Solid Catalysts
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ange.202216327
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12329
    Citation Count: 16
  • Summary Details
    OPEN
    Title: A Collaboration for Guiding the Rational Design of Multielement Solid Catalysts
    Journal Name: Angewandte Chemie International Edition
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/anie.202216327
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Cognitive dysfunction 1 year after COVID‐19: evidence from eye tracking
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51675
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.